Intrinsic Value of S&P & Nasdaq Contact Us

Moolec Science S.A. MLEC NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • LU • USD

SharesGrow Score
32/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$3.00
-59.5%

Financial Health Score — MLEC

Moolec Science S.A. (MLEC) has an overall financial health rating of D+ with a composite score of 0 out of 5.

This suggests the company faces some financial challenges worth monitoring. Rating as of 2025-12-30.

D+
Overall Rating
2025-12-30

Rating History

Date Rating DCF ROE ROA D/E P/E P/B
2025-12-30 D+ -/5 -/5 -/5 -/5 -/5 -/5
2025-12-29 D+ -/5 -/5 -/5 -/5 -/5 -/5
2025-12-26 D+ -/5 -/5 -/5 -/5 -/5 -/5
2025-12-24 D+ -/5 -/5 -/5 -/5 -/5 -/5
2025-12-23 D+ -/5 -/5 -/5 -/5 -/5 -/5
2025-12-22 D+ -/5 -/5 -/5 -/5 -/5 -/5
2025-12-19 D+ -/5 -/5 -/5 -/5 -/5 -/5
2025-12-18 D+ -/5 -/5 -/5 -/5 -/5 -/5
2025-12-17 D+ -/5 -/5 -/5 -/5 -/5 -/5
2025-12-16 D+ -/5 -/5 -/5 -/5 -/5 -/5
2025-12-15 D+ -/5 -/5 -/5 -/5 -/5 -/5
2025-12-12 D+ -/5 -/5 -/5 -/5 -/5 -/5
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message